Release

(redirected from Extended release)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia.

Release

Relieve party to a trade of any previously made obligation concerning that trade, hence allowing the would-be transactor to show the inquiry/order to a new broker.

Release

Written statement by a creditor to the effect that a debtor has either paid off the debt or the debt is otherwise discharged. A creditor may release a lien if the loan has been paid or if other collateral has been offered. Most mortgages contain release clauses indicating under what circumstances the borrower obtains release from the mortgage lien.

release

See release of lien.

Mentioned in ?
References in periodicals archive ?
The company said Exalgo 32mg extended release tablets (hydromorphone HCl) is an opioid agonist indicated for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
Perrigo awarded US FDA for generic Exalgo 32mg extended release analgesic tablets
4 mg/dL for ViramuneEeA IR and 11 mg/dL for nevirapine extended release formulation (ViramuneEeA XR)).
VERxVE Study Demonstrates Efficacy and Safety of 400mg Once Daily Nevirapine (ViramuneEeA) Extended Release (NVP XR) Formulation
ANDAs are being submitted to obtain regulatory approval to market these extended release versions, and this is resulting in some high profile patent infringement lawsuits.
Generic threat to XR drugs? Andree Bates discusses the generic threat to extended release drugs
SECUREL is an proprietary abuse deterrent extended release technology for opioid drugs.
Relmada Therapeutics wins first European patent for SECUREL technology and lead pain therapy product candidate LevoCap ER
Wilds, President and CEO of SCOLR Pharma, said, "While we are disappointed that our initial work on an extended release phenylepherine formulation does not support further commercial development, the successful completion of our second ondansetron study represents the achievement of another important milestone for our Company.
SCOLR Pharma Announces Positive Results from Its Second 24 Hour CDT-Ondansetron Trial
Upon US FDA approval, the extended release formulation of lorcaserin will offer patients a chronic weight management treatment in a once-daily dosing option, added the company.
Eisai and Arena Pharmaceuticals' NDA for extended release formulation of lorcaserin accepted by US FDA for chronic weight management
Statements in this press release about future expectations, plans and prospects for the Company, including the Company's expectations regarding implementation of its revised sales and marketing strategy and its current development plans for an extended release formulation of BiDil, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995.
Kenneth M. Bate Named CEO of NitroMed
According to the company, Oxtellar XR is the first approved novel, oral, once-daily extended release formulation of oxcarbazepine for the treatment of epilepsy.
Supernus wins fifth US patent for antiepileptic drug Oxtellar XR
announced today that Esprit has paid Depomed the $10 million license fee payment due under the parties' license agreement for ProQuin([R]) XR, the extended release formulation of the antibiotic ciprofloxacin developed by Depomed and exclusively licensed in the United States to Esprit.
Depomed Receives $10 Million License Fee from Esprit and Withdraws Arbitration Proceeding
M2 EQUITYBITES-June 1, 2015-Ultragenyx commences Phase III study of aceneuramic acid extended release
Ultragenyx commences Phase III study of aceneuramic acid extended release
s (AMEX: ELI) marketing partner, ECR Pharmaceuticals, has launched Elite's second once-a-day allergy product, under ECR's brand LODRANE 24D, an extended release formulation of brompheniramine maleate and pseudoephedrine HCl.
Elite Pharmaceuticals and ECR Launch Second Once-Daily Antihistamine
M2 PHARMA-June 1, 2015-Ultragenyx commences Phase III study of aceneuramic acid extended release
Ultragenyx commences Phase III study of aceneuramic acid extended release

Financial browser ?
Full browser ?